Return and Refund Policy: What to Check Before You Buy
A clear return and refund policy tells you a lot about a seller before anything goes wrong. Here is what to check before...
block further down, and Blade's raw-block scanner pairs an // inline β swallowing 140 lines of the article. $isDraftPreview = $isDraftPreview ?? false; @endphp
A straight comparison of what GLP-1 support actually costs in Pakistan, why the cheapest injectable is rarely the cheapest course, and what is registered locally.
If you are searching for the cheapest GLP-1 option, you are asking the right question in slightly the wrong way.
The cheapest monthly price and the cheapest route to actually losing weight are frequently different things, and the gap between them is where most money in this market gets wasted.
No GLP-1 medication is registered in Pakistan. Not semaglutide, approved in major markets since 2017. Not tirzepatide. Not liraglutide. Not dulaglutide.
Every injectable pen in the country arrived through personal import, informal medical supply or unregulated resale.
That means there is no regulated price for any of them, no guaranteed supply, and no straightforward way to verify what is in the pen or whether it was kept cold.
Any comparison of "cheapest" starts from that reality rather than from a price list.
Three things make the monthly figure a poor guide.
Dose escalation. Tirzepatide runs 2.5 mg to 15 mg over roughly twenty weeks. Semaglutide escalates over eight to sixteen weeks. Liraglutide reaches full dose in five. The price you are quoted is usually the starting dose, not the one you will settle on.
Consumption rate. A Saxenda pen holds 18 mg and lasts six days at full dose, so you need around five a month. A weekly semaglutide pen typically covers the month. Comparing pen prices without consumption rates produces nonsense.
Course length. STEP 1 measured results at 68 weeks, published in the New England Journal of Medicine. SURMOUNT-1 ran 72 weeks. SCALE ran 56. These are commitments of more than a year.
A cheap month inside a course you cannot finish is not cheap.
Supply interruption is the expense nobody quotes.
If your supplier cannot source your next dose, your course breaks. Appetite returns within days to weeks. Weight regain after stopping GLP-1 medication is common.
Restarting usually means re-escalating from a lower dose, because tolerance to gastrointestinal side effects fades. So you pay again for weeks you have already bought.
Two or three interruptions across a year can mean paying for eighteen months of drug to receive perhaps nine months of continuous effect.
This is not a hypothetical risk in a market supplied entirely by informal import. It is the normal experience.
Some of the cheapest offers are cheap for a reason.
The World Health Organization estimates at least 1 in 10 medical products in low- and middle-income countries is substandard or falsified, and notes these are often sold online or through informal markets.
Where legal supply cannot meet demand, counterfeit supply fills the gap. Falsified semaglutide pens have been found in multiple countries, some containing insulin, some containing nothing.
A pen at half the going rate is not a bargain if it contains saline. It is a total loss, plus whatever harm the wrong contents cause.
Price below the prevailing market rate should increase suspicion, not enthusiasm.
Monthly price tells you very little. Cost per kilogram lost tells you more, because it accounts for how much the drug actually does.
| Drug | Average result | Trial duration |
|---|---|---|
| Tirzepatide 15 mg | 20.9 percent | 72 weeks |
| Semaglutide 2.4 mg | 14.9 percent | 68 weeks |
| Liraglutide 3.0 mg | 8.4 kg | 56 weeks |
| Dulaglutide 1.5 mg | ~3 kg | 40 weeks |
Dulaglutide is often among the cheaper imports, and it produces roughly 3 kg. Paying less per month for a drug that does a fraction of the work is not economising.
Conversely, tirzepatide costs most per month and produces most per month. On cost per kilogram it can compare better than the headline figure suggests, provided you complete the course.
That proviso is doing enormous work in this market.
If cost is the binding constraint, the honest answers are not pens at all.
Dietary change costs nothing and is where all sustainable weight loss ultimately rests. Protein is the strongest lever, and eggs, dahi, chicken and daal deliver it cheaply.
Orlistat is the most accessible weight loss medication in Pakistan. It needs no refrigeration, is not import-dependent and is available generically. It produced 5.8 kg over four years in XENDOS. Its limitation is that it blocks fat only and does nothing for carbohydrates or appetite.
Walking costs nothing.
None of these address appetite the way GLP-1 medication does, and that is precisely the gap people are trying to close when they search for a cheap GLP-1.
For appetite specifically, the practical question is what comes from a transparent, physician-reviewed supplier and can be obtained continuously.
A locally registered GLP-1 supplement is a different category from an imported pharmaceutical pen, and the comparison should be made honestly. METASLIMβ’ is physician-reviewed, which means the process can be checked rather than claimed. It is sublingual, so no cold chain can break. A physician reviews every order before dispatch, and that review is included rather than charged as a separate consultation.
It is not semaglutide or tirzepatide, and it does not produce STEP 1 or SURMOUNT-1 results. Anyone telling you otherwise is misleading you.
What it addresses is the specific failure mode this article is about: paying repeatedly for a course you cannot complete, from a source you cannot verify.
If you are unsure which situation applies to you, take our weight loss quiz for a guided view. Our monthly cost comparison sets the figures side by side, and Wegovy price in Pakistan covers the import structure in detail.
No GLP-1 injectable is registered in Pakistan, so none has a regulated price.
Cheapest per month is a poor guide, because dose escalation, consumption rate and course length all change the total.
Supply interruption is the largest hidden cost, since a broken course means paying twice for the same weeks.
Prices well below the market rate should raise suspicion, given WHO's finding on falsified products.
Cost per kilogram lost is a more useful comparison than cost per month.
Find out what the program costs for a registered, physician-reviewed option.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.
METASLIMβ’ is a physician-guided GLP-1 sublingual program β injection-free appetite support, designed for sustainable weight loss.
None has a regulated price, because no GLP-1 medication is registered in Pakistan. Dulaglutide is often among the cheaper imports but produces only around 3 kg of weight loss, so paying less per month for a much weaker result is not genuine economising.
Because dose escalation raises your cost over time, consumption rates differ enormously between daily and weekly drugs, and trial results describe courses of 56 to 72 weeks. A cheap month inside a course you cannot finish saves nothing.
Supply interruption. If your supplier cannot source the next dose, appetite returns and restarting usually means re-escalating from a lower dose. Two or three breaks across a year can mean paying for eighteen months of drug to get nine months of effect.
Prices well below the prevailing market rate should increase suspicion. WHO estimates at least 1 in 10 medical products in low- and middle-income countries are substandard or falsified, and falsified semaglutide pens have been found containing insulin or nothing at all.
Dietary change costs nothing, with protein the strongest lever through eggs, dahi, chicken and daal. Orlistat is the most accessible weight loss medication, needing no refrigeration and available generically, though it only blocks fat absorption and does nothing for appetite.
Yes. Monthly price ignores how much the drug actually achieves. Tirzepatide costs most per month and produces the most weight loss, so it can compare better per kilogram than the headline figure suggests, provided the course is completed.
It is often among the cheaper imports, but it produces roughly 3 kg of weight loss and is approved for diabetes rather than weight management. On cost per kilogram lost it compares poorly against stronger options.